IL17A and breast cancer: While IL-17- and IL-17-producing cells are significantly insensitive towards chemotherapy in experimental settings29, little is known about the correlation between systemic IL-17 levels and sensitivity towards chemotherapy in clinical settings, especially concerning BC.